The role of plasmacytoid dendritic cells in immunity and tolerance

被引:4
作者
Chen, W
机构
[1] Univ Minnesota, Ctr Canc, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Dept Pediat, Div Hematol Oncol & Bone Marrow Transplantat, Minneapolis, MN 55455 USA
关键词
immunotherapy; indoleamine 2,3-dioxygenase; plasmacytoid dendritic cells; regulatory T cells; type I interferon;
D O I
10.1097/01.mot.0000175464.98185.bf
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Purpose of review Plasmacytoid dendritic cells are key effectors in host innate immunity and orchestrate adaptive immune responses. The role of plasmacytoid dendritic cells in regulating immunity and tolerance is a subject of immense research interest. This review summarizes the current literature regarding the role of plasmacytoid dendritic cells in the induction of regulatory T cells and the maintenance of immunologic tolerance. Recent findings Dendritic cells are critical to the development and peripheral expansion of regulatory T cells. Recent studies have shown that plasmacytoid dendritic cells induce the generation of interleukin-10-producing CD8(+) T suppressor and CD4(+)CD25(+)Foxp3(+) regulatory T cells that potently suppress autologous and allogeneic T cell proliferation. Plasmacytoid dendritic cells express indoleamine 2,3-dioxygenase and produce large amounts of type I interferons that may contribute to regulatory T cell generation and tolerance induction. Increasing evidence in both experimental and clinical transplantation studies demonstrates that plasmacytoid dendritic cells enhance engraftment and prevent graft-versus-host disease. Summary Considerable new evidence suggests that plasmacytoid dendritic cells play an important role in regulatory T cell generation and the maintenance of immune tolerance. Understanding the immune regulatory functions and the mechanisms of plasmacytoid dendritic cells may lead to the development of novel therapies for infectious diseases, autoimmune diseases, cancer, and organ transplantations.
引用
收藏
页码:181 / 185
页数:5
相关论文
共 38 条
[1]   Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells [J].
Arpinati, M ;
Green, CL ;
Heimfeld, S ;
Heuser, JE ;
Anasetti, C .
BLOOD, 2000, 95 (08) :2484-2490
[2]   Dendritic cell populations in Leishmania major-infected skin and draining lymph nodes [J].
Baldwin, T ;
Henri, S ;
Curtis, J ;
O'Keeffe, M ;
Vremec, D ;
Shortman, K ;
Handman, E .
INFECTION AND IMMUNITY, 2004, 72 (04) :1991-2001
[3]   Mucosal CD8α+ DC, with a plasmacytoid phenotype, induce differentiation and support function of T cells with regulatory properties [J].
Bilsborough, J ;
George, TC ;
Norment, A ;
Viney, JL .
IMMUNOLOGY, 2003, 108 (04) :481-492
[4]   The generation of CD25+CD4+ regulatory T cells that prevent allograft rejection does not compromise immunity to a viral pathogen [J].
Bushell, A ;
Jones, E ;
Gallimore, A ;
Wood, K .
JOURNAL OF IMMUNOLOGY, 2005, 174 (06) :3290-3297
[5]   Tolerization of dendritic cells by TS cells:: the crucial role of inhibitory receptors ILT3 and ILT4 [J].
Chang, CC ;
Ciubotariu, R ;
Manavalan, JS ;
Yuan, J ;
Colovai, AI ;
Piazza, F ;
Lederman, S ;
Colonna, M ;
Cortesini, R ;
Dalla-Favera, R ;
Suciu-Foca, N .
NATURE IMMUNOLOGY, 2002, 3 (03) :237-243
[6]  
Chen SS, 2003, ADV FINAN P, V11, P23, DOI 10.1016/S1046-5847(02)11002-7
[7]   Thrombopoietin cooperates with FLT3-hgand in the generation of plasmacytoid dendritic cell precursors from human hematopoietic progenitors [J].
Chen, W ;
Antonenko, S ;
Sederstrom, JM ;
Liang, XQ ;
Chan, ASH ;
Kanzler, H ;
Blom, B ;
Blazar, BR ;
Liu, YJ .
BLOOD, 2004, 103 (07) :2547-2553
[8]   CD4+CD25+ immunoregulatory T cells:: New therapeutics for graft-versus-host disease [J].
Cohen, JL ;
Trenado, A ;
Vasey, D ;
Klatzmann, D ;
Salomon, BL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (03) :401-406
[9]   Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen [J].
de Heer, HJ ;
Hammad, H ;
Soullié, T ;
Hijdra, D ;
Vos, N ;
Willart, MAM ;
Hoogsteden, HC ;
Lambrecht, BN .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (01) :89-98
[10]   CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation [J].
Edinger, M ;
Hoffmann, P ;
Ermann, J ;
Drago, K ;
Fathman, CG ;
Strober, S ;
Negrin, RS .
NATURE MEDICINE, 2003, 9 (09) :1144-1150